Company / SG&A per Share
Amphstar Pharmaceuticals, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.80
FY2025
5-year range
$0.94 / $1.80
FY2021-FY2025
Trend
+52.9%
vs FY2024
Sector context
#87 of 210
Health Care
What the data says
At $1.80, Amphstar Pharmaceuticals, Inc.'s sg&a per share ranks #124 of 210 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $0.94 in FY2022 to $1.80 in FY2025.
Based on SEC 10-K filings.
1.80 in FY2025 with a 5-year CAGR of +10.8%.
Increased from $1.07 to $1.80 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +24.1%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
#124 of 210 in Health CareTop 59% of 210This company $1.80 Sector average $40.75
▼
-95.6% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 52.9% year-over-year.
- Ranks #87 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.80 | +52.9% |
| FY2024 | $1.18 | +10.1% |
| FY2023 | $1.07 | +13.4% |
| FY2022 | $0.94 | -12.8% |
| FY2021 | $1.08 | +0.1% |
| FY2020 | $1.08 | +0.3% |
| FY2019 | $1.08 | +0.8% |
| FY2018 | $1.07 | +11.3% |
| FY2017 | $0.96 | +3.9% |
| FY2016 | $0.93 | -0.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026